TIL Instil Bio, Inc.
Healthcare$8.12-0.73%ClosedMarket Cap: $55.1M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.50
P/S
0.00
EV/EBITDA
-1.12
DCF Value
$-11.77
FCF Yield
-60.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-39.8%
ROA
-23.6%
ROIC
-27.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-6.0M | $-4.2M | $— | — |
| Q4 null | $0.00 | NaN% | $-9.6M | $-8.2M | $— | — |
| FY null | $0.00 | -Infinity% | $-52.9M | $-71.4M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-15.0M | $-13.6M | $— | — |
| Q2 null | $0.00 | NaN% | $-23.4M | $-21.4M | $— | — |
| Q1 null | $0.00 | NaN% | $-30.6M | $-28.2M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-11.5M | $-11.9M | $— | — |
| FY null | $0.00 | NaN% | $-73.5M | $-74.1M | $— | — |
| Q3 null | $0.00 | NaN% | $-23.6M | $-23.0M | $— | — |
| Q2 null | $0.00 | NaN% | $-14.1M | $-14.9M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-19.7M | $-24.3M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-12.9M | $-12.9M | $-1.99 | — |